Evidence map›Paper›PMID 28776337›Full record

ArticleJournal of Korean medical science2017

Changes in the Serotype Distribution among Antibiotic Resistant Carriage Streptococcus pneumoniae Isolates in Children after the Introduction of the Extended-Valency Pneumococcal Conjugate Vaccine.

Joon Kee Lee, Ki Wook Yun, Eun Hwa Choi, Sun Jung Kim, Seong Yeon Lee, Hoan Jong Lee

Abstract read
In one paragraph

Article in Journal of Korean medical science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Distribution of Serotypes Causing Invasive Pneumococcal Disease in Children From High-Income Countries and the Impact of Pediatric Pneumococcal Vaccination.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  9. Antibiotic resistance ofFrontiers in public health · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Changes in Serotype ofInfection & chemotherapy · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Joon Kee LeeDepartment of Pediatrics, Seoul National University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-8191-0812
Ki Wook YunDepartment of Pediatrics, Seoul National University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-0798-6779
Eun Hwa ChoiDepartment of Pediatrics, Seoul National University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-5857-0749
Sun Jung KimDepartment of Pediatrics, Seoul National University Children's Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0002-4668-3690
Seong Yeon LeeDepartment of Pediatrics, Seoul National University Children's Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0002-0800-8125
Hoan Jong LeeDepartment of Pediatrics, Seoul National University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-9643-3692

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigated the serotype distribution and antimicrobial resistance of 3,820 nasopharyngeal Streptococcus pneumoniae isolates from infants and children who presented with respiratory symptoms at Seoul National University Children's Hospital from July 2010 to June 2015 after the introduction of the extended-valency pneumococcal conjugate vaccines (PCVs). Serotypes and antimicrobial susceptibility were determined using the Quellung reaction and E-test, respectively. S. pneumoniae was isolated from 397 (10.4%) specimens. The most common serotypes were 19A (14.0%), 23A (12.8%), 15B/C (10.7%), 11A (10.1%), 6C (7.8%), and 6A (6.3%) among the typeable pneumococci (n = 335). The PCV serotype proportions significantly decreased (59.1% in 2010/11 to 17.0% in 2014/15, P < 0.001), whereas the non-PCV serotype proportions significantly increased (40.9% in 2010/11 to 83.0% in 2014/15, P < 0.001). The non-susceptibility rates for penicillin (oral), penicillin (parenteral, non-meningitis), cefotaxime, and erythromycin were 97.8%, 22.8%, 27.7%, and 95.5%, respectively. The proportions of PCV serotypes responsible for non-susceptibility to penicillin (parenteral, non-meningitis) and multidrug resistance significantly decreased (80.8% to 21.1%, P < 0.001 and 64.3% to 12.3%, P < 0.001, respectively), whereas the non-PCV serotype proportions significantly increased (19.2% to 78.9%, P < 0.001 and 35.7% to 87.7%, P < 0.001, respectively). Serotypes 23A and 15B/C demonstrated significant proportional increase among the antibiotics resistant strains. Thus, the PCV serotype proportions decreased and the non-PCV serotype proportions increased among nasopharyngeal carriage pneumococci after the introduction of extended-valency PCVs in Korea. Antimicrobial non-susceptibility rates for penicillin and erythromycin remain high despite the decrease in the proportion of PCV serotypes responsible for antimicrobial resistance over time.

Indexed as

AdolescentAnti-Bacterial AgentsCefotaximeChildChild, PreschoolDrug Resistance, BacterialErythromycinFemaleHumansInfantInfant, NewbornMaleMicrobial Sensitivity TestsNasopharynxPenicillinsPneumococcal InfectionsAnti-Bacterial AgentsCefotaximeErythromycinPenicillinsPneumococcal VaccinesVaccines, ConjugateAntimicrobial ResistancePneumococcal Conjugate VaccinesSerotypeStreptococcus pneumoniae

Identifiers

PMID28776337
PMCPMC5546961

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.